Chimerism Analysis Is Predictive of Relapse-Free Survival After Allogeneic Transplantation for MDS

被引：0
|
作者：
Mohan, Sanjay R. [1 ]
Rybicki, Lisa [1 ]
Kalaycio, Matt [1 ]
Sobecks, Ronald [1 ]
Bolwell, Brian J. [1 ]
Copelan, Edward A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [1] Establishment of a Predictive Model of GvHD-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm
    Kanda, Junya
    Arai, Yasuyuki
    Kondo, Tadakazu
    Ishikawa, Takayuki
    Ueda, Yasunori
    Imada, Kazunori
    Akasaka, Takashi
    Yonezawa, Akihito
    Yago, Kazuhiro
    Nohgawa, Masaharu
    Anzai, Naoyuki
    Moriguchi, Toshinori
    Kitano, Toshiyuki
    Itoh, Mitsuru
    Arima, Nobuyoshi
    Takeoka, Tomoharu
    Watanabe, Mitsumasa
    Hirata, Hirokazu
    Asagoe, Kosuke
    Miyanishi, Masanori
    Miyatsuka, Isao
    An, Le My
    Takaori-Kondo, Akifumi
    BLOOD, 2019, 134
  • [2] Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
    Iwasaki, Makoto
    Kanda, Junya
    Arai, Yasuyuki
    Kondo, Tadakazu
    Ishikawa, Takayuki
    Ueda, Yasunori
    Imada, Kazunori
    Akasaka, Takashi
    Yonezawa, Akihito
    Yago, Kazuhiro
    Nohgawa, Masaharu
    Anzai, Naoyuki
    Moriguchi, Toshinori
    Kitano, Toshiyuki
    Itoh, Mitsuru
    Arima, Nobuyoshi
    Takeoka, Tomoharu
    Watanabe, Mitsumasa
    Hirata, Hirokazu
    Asagoe, Kosuke
    Miyatsuka, Isao
    An, Le My
    Miyanishi, Masanori
    Takaori-Kondo, Akifumi
    BLOOD ADVANCES, 2022, 6 (08) : 2618 - 2627
  • [3] Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation
    Roberto Crocchiolo
    Alessio Signori
    Mohamad Sobh
    Helene Labussiere
    Myriam Renault
    Fiorenza Barraco
    Franck Nicolini
    Mauricette Michallet
    Annals of Hematology, 2020, 99 : 1149 - 1150
  • [4] Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation
    Crocchiolo, Roberto
    Signori, Alessio
    Sobh, Mohamad
    Labussiere, Helene
    Renault, Myriam
    Barraco, Fiorenza
    Nicolini, Franck
    Michallet, Mauricette
    ANNALS OF HEMATOLOGY, 2020, 99 (05) : 1149 - 1150
  • [5] CHIMERISM AND LEUKEMIA RELAPSE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    FRASSONI, F
    SESSAREGO, M
    PANARELLO, C
    BACIGALUPO, A
    REPETTO, M
    RAFFO, MR
    PIAGGIO, G
    VANLINT, MT
    LERCARI, G
    MARMONT, AM
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 402 - 402
  • [6] Chimerism kinetics of unfractionated bone marrow in the first year after allogeneic haematopoietic cell transplantation is predictive of relapse in patients with AML and MDS
    Papalexandri, A.
    Apostolou, C.
    Voutiadou, G.
    Touloumenidou, T.
    Zorbas, I.
    Batsis, I.
    Smias, C.
    Stalika, E.
    Paleta, A.
    Sakellari, I.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S198 - S198
  • [7] Chimerism Kinetics of Unfractionated Bone Marrow In the First Year After Allogeneic Hematopoietic Cell Transplantation Is Predictive of Relapse In Patients with AML and MDS.
    Papalexandri, Apostolia
    Apostolou, Chryssa
    Voutiadou, Georgia
    Touloumenidou, Tasoula
    Zorbas, Ioannis
    Batsis, Ioannis
    Smias, Christos
    Stalika, Evangelia
    Paleta, Angeliki
    Sakellari, Ioanna
    Anagnostopoulos, Achilles
    BLOOD, 2010, 116 (21) : 555 - 556
  • [8] GVHD-Free, Relapse-Free Survival(GRFS)after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: KHCC Experience
    Abu Shanap, M.
    Natsheh, A.
    Rihani, R.
    Hashem, H.
    Khattab, E.
    Ma'Koseh, M.
    Da'Na, W.
    Saadeh, S.
    Al Far, R.
    Halahleh, K.
    Abu Jazar, H.
    Tbakhi, A.
    Sultan, I.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S310 - S311
  • [9] Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
    Park, Sung-Soo
    Jeon, Young-Woo
    Min, Gi June
    Park, Silvia
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Yoo-Jin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 63 - 72
  • [10] TREC after allogeneic stem cell transplantation as a predictive marker for relapse after AML and MDS/MPS
    Uzunel, M.
    Sairafi, D.
    Mattsson, J.
    Uhlin, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S133 - S133
12345